Scanvio Medical AG

Endometriosis affects 10% of the female population in childbearing age, and patients face a delay in diagnosis of 8-12 years. This causes a significant impact on the quality of life for patients due to pain and risk of infertility and also provides a large economic burden to society. Scanvio is developing intelligent algorithms to replace the gold standard invasive laparoscopy with non-invasive AI-supported ultrasound for faster and more accessible diagnosis of endometriosis, reducing the time for diagnosis from 8-12 years to 1-3 years. The founding team combines first-class expertise in the field of machine learning, top competencies in the field of ultrasound, and experience from a successful serial entrepreneur.